Targeted inhibition of DNMT, EZH2, HDACs, and lysine-specific demethylase 1 (LSD1) has been shown to induce the expression of chemokines resulting in increased T cell infiltration into the tumor microenvironment and enhanced antitumor immunity (Fig. 4F). The gene discussed is EZH2; the disease is neoplasm.